Novartis Farma SpA v Agenzia Italiana del Farmaco (AIFA).

Core Citations

WORK EXPRESSION OF in

• Novartis Farma SpA v Agenzia Italiana del Farmaco (AIFA).

This document cites

• F. Hoffmann-La Roche Ltd and Others v Autorità Garante della Concorrenza e del Mercato.
• Karl Berger v Freistaat Bayern.
• European Commission v Republic of Poland.
• Novartis Pharma GmbH v Apozyt GmbH.
• Aventis Pharma Deutschland GmbH v Kohlpharma GmbH and MTK Pharma Vertriebs-GmbH.



See all quotations

• Abcur AB v Apoteket Farmaci AB and Apoteket AB.
• The Queen, on the application of Association of the British Pharmaceutical Industry v Medicines and Healthcare Products Regulatory Agency.
• Aleksei Petruhhin v Latvijas Republikas Ģenerālprokuratūra.
• Criminal proceedings against Fabio Caronna.
• A. Menarini Industrie Farmaceutiche Riunite Srl and Others v Ministero della Salute and Agenzia Italiana del Farmaco (AIFA) (C-352/07), Sanofi Aventis SpA v Agenzia Italiana del Farmaco (AIFA) (C-353/07), IFB Stroder Srl v Agenzia Italiana del Farmaco (AIFA) (C-354/07), Schering Plough SpA v Agenzia Italiana del Farmaco (AIFA) (C-355/07), Bayer SpA v Agenzia Italiana del Farmaco (AIFA) and Ministero della Salute (C-356/07), Simesa SpA v Ministero della Salute and Agenzia Italiana del Farmaco (AIFA) (C-365/07), Abbott SpA v Ministero della Salute and Agenzia Italiana del Farmaco (AIFA) (C-366/07), Baxter SpA v Agenzia Italiana del Farmaco (AIFA) (C-367/07) and SALF SpA v Agenzia Italiana del Farmaco (AIFA) and Ministero della Salute (C-400/07).
• Persidera SpA v Autorità per le Garanzie nelle Comunicazioni and Ministero dello Sviluppo Economico delle Infrastrutture e dei Trasporti.
• Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
• Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004 (Text with EEA relevance)
• Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Union procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (Text with EEA relevance)Text with EEA relevance
• Council Directive 89/105/EEC of 21 December 1988 relating to the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of national health insurance systems
• Consolidated version of the Treaty on the Functioning of the European Union 2016/C 202/01
• Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004 (Text with EEA relevance)
• Regulation (EU) No 1027/2012 of the European Parliament and of the Council of 25 October 2012 amending Regulation (EC) No 726/2004 as regards pharmacovigilance Text with EEA relevance
• Directive 2012/26/EU of the European Parliament and of the Council of 25 October 2012 amending Directive 2001/83/EC as regards pharmacovigilance Text with EEA relevance
• Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (Text with EEA relevance)
• Treaty establishing the European Community